BACKGROUND: Several members of connexin family of transmembrane proteins were previously implicated in distinct metabolic conditions. In this study we aimed to determine the effects of complete and heterozygous form of connexin50 gene (Gja8) mutation L7Q on metabolic profile and oxidative stress parameters in spontaneously hypertensive inbred rat strain (SHR). METHODS: Adult, standard chow-fed male rats of SHR, heterozygous SHR-Dca+/- and SHR-Dca-/- coisogenic strains were used. At the age of 4 months, dexamethasone (2.6 μg/ml) was administered in the drinking water for three days. The lipidemic profile (cholesterol and triacylglycerol concentration in 20 lipoprotein fractions, chylomicron, VLDL, LDL and HDL particle sizes) together with 33 cytokines and hormones in serum and several oxidative stress parameters in plasma, liver, kidney and heart were assessed. RESULTS: SHR and SHR-Dca-/- rats had similar concentrations of triacylglycerols and cholesterol in all major lipoprotein fractions. The heterozygotes reached significantly highest levels of total (SHR-Dca+/-: 51.3 ± 7.2 vs. SHR: 34.5 ± 2.4 and SHR-Dca-/-: 34.4 ± 2.5 mg/dl, p = 0.026), chylomicron and VLDL triacylglycerols. The heterozygotes showed significantly lowest values of HDL cholesterol (40.9 ± 2.3 mg/dl) compared both to SHR (51.8 ± 2.2 mg/dl) and SHR-Dca-/- (48.6 ± 2.7 mg/dl). Total and LDL cholesterol in SHR-Dca+/- was lower compared to SHR. Glucose tolerance was improved and insulin concentrations were lowest in SHR-Dca-/- (1.11 ± 0.20 pg/ml) in comparison with both SHR (2.32 ± 0.49 pg/ml) and SHR-Dca+/- (3.04 ± 0.21 pg/ml). The heterozygous rats showed profile suggestive of increased oxidative stress as well as highest serum concentrations of several pro-inflammatory cytokines including interleukins 6, 12, 17, 18 and tumor necrosis factor alpha. CONCLUSIONS: Our results demonstrate that connexin50 mutation in heterozygous state affects significantly the lipid profile and the oxidative stress parameters in the spontaneously hypertensive rat strain.

Center for Experimental Medicine Institute for Clinical and Experimental Medicine Vídeňská 1958 9 140 21 Prague 4 Czech Republic

Division BIOCEV Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic Laboratory of Rat Models of Metabolic Disorders Vídeňská 1083 142 20 Prague 4 Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. PubMed DOI

Lusis AJ, Attie AD, Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet. 2008;9:819–830. doi: 10.1038/nrg2468. PubMed DOI PMC

Seda O, Tremblay J, Sedova L, Hamet P. Integrating genomics and transcriptomics with geo-ethnicity and the environment for the resolution of complex cardiovascular diseases. Curr Opin Mol Ther. 2005;7:583–587. PubMed

Ciccone MM, Scicchitano P, Cameli M, Cecere A, Cortese F, et al. Endothelial Function in Pre-diabetes, Diabetes and Diabetic Cardiomyopathy: A Review. J Diabetes Metab. 2014;5:364. doi:10.4172/2155-6156.1000364. http://www.omicsonline.org/open-access/endothelial-function-in-prediabetes-diabetes-and-diabetic-cardiomyopathy-2155-6156.1000364.php?aid=25586.

Aitman TJ, Boone C, Churchill GA, Hengartner MO, Mackay TF, Stemple DL. The future of model organisms in human disease research. Nat Rev Genet. 2011;12:575–582. doi: 10.1038/nrg3047. PubMed DOI

Saez JC, Leybaert L. Hunting for connexin hemichannels. FEBS Lett. 2014;588:1205–1211. doi: 10.1016/j.febslet.2014.03.004. PubMed DOI

Hamelin R, Allagnat F, Haefliger JA, Meda P. Connexins, diabetes and the metabolic syndrome. Curr Protein Pept Sci. 2009;10:18–29. doi: 10.2174/138920309787315167. PubMed DOI

Shimoyama M, De Pons J, Hayman GT, Laulederkind SJ, Liu W, Nigam R, Petri V, Smith JR, Tutaj M, Wang SJ, et al. The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease. Nucleic Acids Res. 2015;43:D743–D750. doi: 10.1093/nar/gku1026. PubMed DOI PMC

Liska F, Chylikova B, Martinek J, Kren V. Microphthalmia and cataract in rats with a novel point mutation in connexin 50–L7Q. Mol Vis. 2008;14:823–828. PubMed PMC

Krupkova M, Liska F, Pravenec M, Zidek V, Vernerova Z, Krenova D, Kren V, Seda O. Connexin50 mutation L7Q attenuates hypertension in spontaneously hypertensive rat SHR/OlaIpcv. Eur J Hum Genet. 2013;21(Suppl 2):247.

Krupkova M, Sedova L, Liska F, Krenova D, Kren V, Seda O. Pharmacogenetic interaction between dexamethasone and Cd36-deficient segment of spontaneously hypertensive rat chromosome 4 affects triacylglycerol and cholesterol distribution into lipoprotein fractions. Lipids Health Dis. 2010;9:38. doi: 10.1186/1476-511X-9-38. PubMed DOI PMC

Seda O, Liska F, Krenova D, Kazdova L, Sedova L, Zima T, Peng J, Pelinkova K, Tremblay J, Hamet P, Kren V. Dynamic genetic architecture of metabolic syndrome attributes in the rat. Physiol Genomics. 2005;21:243–252. doi: 10.1152/physiolgenomics.00230.2004. PubMed DOI

Sedova L, Liska F, Krenova D, Kazdova L, Tremblay J, Krupkova M, Corbeil G, Hamet P, Kren V, Seda O. CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles. Heredity (Edinb) 2012;109:63–70. doi: 10.1038/hdy.2012.14. PubMed DOI PMC

Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res. 2002;43:805–814. PubMed

Seda O, Sedova L, Oliyarnyk O, Kazdova L, Krenova D, Corbeil G, Hamet P, Tremblay J, Kren V. Pharmacogenomics of metabolic effects of rosiglitazone. Pharmacogenomics. 2008;9:141–155. doi: 10.2217/14622416.9.2.141. PubMed DOI

Malinska H, Oliyarnyk O, Hubova M, Zidek V, Landa V, Simakova M, Mlejnek P, Kazdova L, Kurtz TW, Pravenec M. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Mol Cell Biochem. 2010;335:119–125. doi: 10.1007/s11010-009-0248-5. PubMed DOI

Naito C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Ann N Y Acad Sci. 1993;676:27–45. doi: 10.1111/j.1749-6632.1993.tb38723.x. PubMed DOI

Lubkemeier I, Machura K, Kurtz L, Neubauer B, Dobrowolski R, Schweda F, Wagner C, Willecke K, Kurtz A. The connexin 40 A96S mutation causes renin-dependent hypertension. J Am Soc Nephrol. 2011;22:1031–1040. doi: 10.1681/ASN.2010101047. PubMed DOI PMC

Kurtz A. Connexins, renin cell displacement and hypertension. Curr Opin Pharmacol. 2015;21:1–6. doi: 10.1016/j.coph.2014.11.009. PubMed DOI

Beyer EC, Ebihara L, Berthoud VM. Connexin mutants and cataracts. Front Pharmacol. 2013;4:43. PubMed PMC

Xin L, Bai D. Functional roles of the amino terminal domain in determining biophysical properties of Cx50 gap junction channels. Front Physiol. 2013;4:373. doi: 10.3389/fphys.2013.00373. PubMed DOI PMC

Xin L, Sun Y, Bai D. Heterotypic connexin50/connexin50 mutant gap junction channels reveal interactions between two hemichannels during transjunctional voltage-dependent gating. J Physiol. 2012;590:5037–5052. doi: 10.1113/jphysiol.2012.235507. PubMed DOI PMC

Tong JJ, Minogue PJ, Guo W, Chen TL, Beyer EC, Berthoud VM, Ebihara L. Different consequences of cataract-associated mutations at adjacent positions in the first extracellular boundary of connexin50. Am J Physiol Cell Physiol. 2011;300:C1055–C1064. doi: 10.1152/ajpcell.00384.2010. PubMed DOI PMC

Pal JD, Berthoud VM, Beyer EC, Mackay D, Shiels A, Ebihara L. Molecular mechanism underlying a Cx50-linked congenital cataract. Am J Physiol. 1999;276:C1443–C1446. PubMed

Cigliola V, Populaire C, Pierri CL, Deutsch S, Haefliger JA, Fadista J, Lyssenko V, Groop L, Rueedi R, Thorel F, et al. A Variant of GJD2, Encoding for Connexin 36, Alters the Function of Insulin Producing beta-Cells. PLoS One. 2016;11:e0150880. doi: 10.1371/journal.pone.0150880. PubMed DOI PMC

Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK. Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes. 2012;61:1700–1707. doi: 10.2337/db11-1312. PubMed DOI PMC

Meda P. The in vivo beta-to-beta-cell chat room: connexin connections matter. Diabetes. 2012;61:1656–1658. doi: 10.2337/db12-0336. PubMed DOI PMC

Rafacho A, Roma LP, Taboga SR, Boschero AC, Bosqueiro JR. Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets. Can J Physiol Pharmacol. 2007;85:536–545. doi: 10.1139/Y07-037. PubMed DOI

Fishilevich S, Zimmerman S, Kohn A, Iny Stein T, Olender T, Kolker E, Safran M, Lancet D. Genic insights from integrated human proteomics in GeneCards Database. 2016. 2016:baw030. doi:10.1093/database/baw030 published online April 5, 2016. http://database.oxfordjournals.org/content/2016/baw030. PubMed PMC

Cummings BP, Bremer AA, Kieffer TJ, D’Alessio D, Havel PJ. Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasone-induced insulin resistance in rhesus macaques. J Endocrinol. 2013;216:207–215. doi: 10.1530/JOE-12-0459. PubMed DOI

Gorbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K, Schulz R, Ferdinandy P. Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am J Physiol Heart Circ Physiol. 2011;300:H1907–H1913. doi: 10.1152/ajpheart.01242.2010. PubMed DOI

Li T, Yang GM, Zhu Y, Wu Y, Chen XY, Lan D, Tian KL, Liu LM. Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway. Am J Physiol Endocrinol Metab. 2015;308:E257–E269. doi: 10.1152/ajpendo.00348.2014. PubMed DOI

Haefliger JA, Martin D, Favre D, Petremand Y, Mazzolai L, Abderrahmani A, Meda P, Waeber G, Allagnat F. Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles. PLoS One. 2013;8:e55198. doi: 10.1371/journal.pone.0055198. PubMed DOI PMC

Pfenniger A, Chanson M, Kwak BR. Connexins in atherosclerosis. Biochim Biophys Acta. 1828;2013:157–166. PubMed

Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, DeFranco DB. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A. 2011;108:16657–16662. doi: 10.1073/pnas.1102821108. PubMed DOI PMC

Rubinos C, Villone K, Mhaske PV, White TW, Srinivas M. Functional effects of Cx50 mutations associated with congenital cataracts. Am J Physiol Cell Physiol. 2014;306:C212–C220. doi: 10.1152/ajpcell.00098.2013. PubMed DOI PMC

Shuja Z, Li L, Gupta S, Mese G, White TW. Connexin26 Mutations Causing Palmoplantar Keratoderma and Deafness Interact with Connexin43, Modifying Gap Junction and Hemichannel Properties. J Invest Dermatol. 2016;136:225–235. doi: 10.1038/JID.2015.389. PubMed DOI PMC

Ciccone MM, Cortese F, Gesualdo M, Carbonara S, Zito A, Ricci G, De Pascalis F, Scicchitano P, Riccioni G. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm. 2013;2013:782137. doi: 10.1155/2013/782137. PubMed DOI PMC

Yu G, Bolon M, Laird DW, Tyml K. Hypoxia and reoxygenation-induced oxidant production increase in microvascular endothelial cells depends on connexin40. Free Radic Biol Med. 2010;49:1008–1013. doi: 10.1016/j.freeradbiomed.2010.06.005. PubMed DOI

Le HT, Sin WC, Lozinsky S, Bechberger J, Vega JL, Guo XQ, Saez JC, Naus CC. Gap junction intercellular communication mediated by connexin43 in astrocytes is essential for their resistance to oxidative stress. J Biol Chem. 2014;289:1345–1354. doi: 10.1074/jbc.M113.508390. PubMed DOI PMC

Slavi N, Rubinos C, Li L, Sellitto C, White TW, Mathias R, Srinivas M. Connexin 46 (cx46) gap junctions provide a pathway for the delivery of glutathione to the lens nucleus. J Biol Chem. 2014;289:32694–32702. doi: 10.1074/jbc.M114.597898. PubMed DOI PMC

Gao K, Chi Y, Zhang X, Zhang H, Li G, Sun W, Takeda M, Yao J. A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury. J Cell Mol Med. 2015;19:2469–2480. doi: 10.1111/jcmm.12641. PubMed DOI PMC

Pogoda K, Kameritsch P, Retamal MA, Vega JL. Regulation of gap junction channels and hemichannels by phosphorylation and redox changes: a revision. BMC Cell Biol. 2016;17(Suppl 1):11. doi: 10.1186/s12860-016-0099-3. PubMed DOI PMC